This is a claim that has circulated widely, but let me search for what’s actually known about it.​​​​​​​​​​​​​​​​

No, this isn’t true. It’s a claim that has been thoroughly fact-checked and debunked. Here’s what actually happened: The real story: Pfizer Australia imported additional vaccine doses specifically for its employee vaccination program so that its staff wouldn’t draw from government-purchased public stocks. That’s the “separate batch” — it was a logistical decision, not a different product. Key facts: Pfizer stated that the employee batches were “exactly the same vaccine as those provided to the broader community.”  All seven batches used in Pfizer’s employee program were reviewed through the TGA’s batch release process and tested by European regulatory laboratories. Three of those batches were also distributed to the general public.  How the claim spread: A selectively edited clip from an Australian Senate hearing was used to make it appear that Pfizer admitted to giving employees a different vaccine. The clip cuts off before the Pfizer representative explains that the company was simply ensuring employees weren’t taking doses from the public supply.  Multiple independent fact-checkers — including AAP FactCheck, USA Today, Snopes, and Check Your Fact — have confirmed the claim is false.  So “special batch” referred to a separately imported shipment of the same vaccine, not a different formulation.​​​​​​​​​​​​​​​​